# Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors

> **NCT03068832** · PHASE1 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Pediatric Brain Tumor

## Interventions

- **BIOLOGICAL:** Personalized peptide vaccine
- **DRUG:** Poly ICLC
- **PROCEDURE:** Peripheral blood draw

## Key facts

- **NCT ID:** NCT03068832
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09-30
- **Primary completion:** 2023-03-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Made the decision to not go forward with the study
- **Last updated:** 2021-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03068832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03068832, "Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03068832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*